Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-13

Clinical Trial Update: Study of ST-100 as Treatment for Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ST-100 for dry eye disease has completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ST-100

Snippet

Sponsor: Stuart Therapeutics, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-03-13